{
    "organizations": [],
    "uuid": "20efce0686e97449ed864ffdede4e6601c3de36a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-protalix-biotherapeutics-reports-2/brief-protalix-biotherapeutics-reports-2017-full-year-results-and-provides-corporate-update-idUSASB0C8XX",
    "ord_in_thread": 0,
    "title": "BRIEF-Protalix Biotherapeutics Reports 2017 Full Year Results And Provides Corporate Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Protalix Biotherapeutics Inc:\n* PROTALIX BIOTHERAPEUTICS REPORTS 2017 FULL YEAR RESULTS AND PROVIDES CORPORATE UPDATE\n* PROTALIX BIOTHERAPEUTICS INC - ON DEC 31, 2017, HAD $51.2 MILLION OF CASH AND CASH EQUIVALENTS, COMPARED TO $63.3 MILLION AT DEC 31, 2016 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T20:38:00.000+02:00",
    "crawled": "2018-03-06T14:50:17.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "protalix",
        "biotherapeutics",
        "inc",
        "protalix",
        "biotherapeutics",
        "report",
        "full",
        "year",
        "result",
        "provides",
        "corporate",
        "update",
        "protalix",
        "biotherapeutics",
        "inc",
        "dec",
        "million",
        "cash",
        "cash",
        "equivalent",
        "compared",
        "million",
        "dec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}